NOVA Genomics – Reimagining the Future of Genetic Testing
Source: https://www.novagenomics.org
Archived: 2026-04-23 16:40
NOVA Genomics – Reimagining the Future of Genetic Testing
Reimagining the Future of Genetic Testing
Revolutionizing the preimplantation genetic testing laboratory allowing for greater access, accuracy, and clinical impact
CONTACT OUR TEAM TO LEARN MORE
Transforming Genetic Testing with
Experience
and
Innovation
At NOVA Genomics, we are reimagining preimplantation genetic testing (PGT). Founded by industry veterans Dr. Gary Harton and Cynthia Hudson, NOVA brings together cutting-edge technology and a new standard of care to help patients and IVF providers navigate the complexities of genetic testing through informed decision making.
Our team is developing an advanced platform that will serve as the foundation for our contribution to the future of reproductive genetic testing.
UNDERSTANDING PREIMPLANTATION GENETIC TESTING
PGT is a genetic screening test performed on embryos created by in vitro fertilization (IVF). PGT results may be used by physicians in the IVF clinic setting in their clinical decision making.
At NOVA Genomics, we analyze embryos for chromosomal abnormalities, such as extra or missing chromosomes, as well as single-gene disorders and structural chromosomal rearrangements that can lead to inherited genetic conditions.
PGT is offered as three options: PGT-A, PGT-M, and PGT-SR, each designed to address different genetic concerns.
PGT-
A
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a genetic test to screen embryos for numerical chromosome changes (i.e. Down syndrome). This test identifies embryos predicted to have the expected complement of chromosomes.
PGT-
SR
Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) is a genetic test used during IVF to screen embryos for unbalanced chromosomal structures caused by inherited rearrangements like translocations or inversions.
PGT-
M
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a genetic test performed on embryos to screen for and diagnose inherited variants that cause monogenic (single-gene) disorders (i.e. cystic fibrosis, sickle cell anemia).
nova genomics: A
Modern Approach
to Preimplantation Genetic Testing
NOVA Genomics was founded by two pioneers in the IVF industry. Cynthia Hudson and Dr. Gary Harton, who bring over 50 years of combined experience in Embryology and Preimplantation Genetic Testing (PGT). After decades of work, they recognized critical gaps in the field, including outdated lab technologies, growing concerns about quality and compliance, and ongoing debates over the clinical value of PGT.
Their response was to build a next-level PGT lab from the ground up, focused on expanding access to advanced genetic services for families in need of PGT-SR and PGT-M testing for inherited conditions.
our mission
NOVA Genomics exists to transform preimplantation genetic testing by making high-precision, clinically meaningful insights accessible to every IVF journey. We are driven to close the gaps in technology, quality, and equity by building a new model for genetic testing – one rooted in scientific excellence, patient-centered care, and uncompromising standards.
Driven by this mission, NOVA Genomics is transforming the PGT experience through:
leadership
in education
We are committed to educating our customers and the broader community about the science and benefits of PGT. By promoting awareness and understanding, we support informed decision-making throughout the IVF and genetic screening process.
excellence in
genetic counseling
We've partnered with premier GC services to offer our patients unparalleled support and education throughout their journey. With flexible communication options including live consultations and results discussions with certified genetic counselors, patients and providers are supported both before and after testing.
strategic
partnerships
With an industry-leading management team, we are forging strategic partnerships with leading reagent and software providers to guarantee that our patients and clinical partners have access to the most advanced, reliable, and effective tools in reproductive genetics.
innovation
technology platform
We are developing a new and more effective PGT platform that prioritizes high-quality genetic insights. Our focus is on delivering accurate results that put patient needs and scientific integrity at the forefront of fertility care.
Our partners
PatientFi is designed to take the financial stress out of building your family. Our customized fertility financing solutions make it easier to focus on what really matters—your treatment and your journey—not the cost.
Every plan is tailored to your needs, with flexible terms and simple monthly payments that work within your budget. Whether you’re just starting or continuing treatment, we’ve got you covered.
Expert genetic counseling, seamlessly integrated.
Through our partnership with Tandem Genetics, clinics have access to experienced telehealth counselors for pre- and post-testing sessions. This service streamlines care and ensures individuals pursuing IVF with PGT receive clear guidance on results and next steps.
Learn more about Tandem Genetics’ virtual counseling services.
IVF Store, your Everything IVF partner, is a full-service online marketplace representing the industry’s finest products and solutions, backed by exceptional customer service and support. By adding convenient access to advanced genetic testing alongside their comprehensive offerings, we give clinics a single, reliable partner for both everyday needs and next-generation services.
Meet the
Experts
Behind NOVA Genomics
founders
Gary Harton PhD
Chief Scientific Officer
Gary brings 35 years of experience covering embryology and andrology, molecular and classic cytogenetics, next-generation sequencing, and clinical genetics.
Cynthia Hudson
Chief Executive Officer
Cynthia is a medical technologist with over 25 years of experience as an embryologist, entrepreneur, and product specialist.
clinical team
Harvey Stern MD, PhD (FABMGG)
Medical Director
Dr. Stern is a Board-Certified Clinical & Molecular Geneticist specializing in Reproductive Genetics. He has over 30 years of experience as Medical Director of Preimplantation Genetic Testing and Molecular Genetics laboratories.
Mary Sands, MS, CGC
Director of Clinical Services
Mary is a Certified Genetic Counselor specializing in reproductive genetics with over 20 years of experience managing laboratory and clinical integration in the IVF clinic setting.
laboratory team
Brian Mariani PhD
Director Laboratory Services
Brian has conducted extensive research in cell and molecular biology, exploring aspects of gene organization and how genetic information is expressed and regulated in the context of early developmental biology processes.
Khoa Tran
Lab Team Lead SNV
Khoa has 20 years of research and clinical experience applying molecular diagnostics to the field of reproductive genetics.
Veronica Novik PhD
Lab Team Lead CNV
Veronica is a laboratory professional with over two decades of experience in academic research and clinical laboratory leadership. Recently serving as Assistant Director at the Genetics and IVF Institute, she led cutting-edge initiatives in PGT and molecular diagnostics.
Gabrielle Byers
BS Lab Intern
Gabrielle is a current biotechnology graduate student with a background in Biology and a growing foundation in Computational Genomics and Molecular Science.
Advisors
Darren K Griffin PHD
Professor Darren Griffin is a distinguished geneticist and reproductive medicine expert who serves as Honorary Professor at University College London and the University of Kent, and CEO of GriffinLore Ltd. With over 400 peer-reviewed publications and a citation count exceeding 24,000, he is internationally recognized for his groundbreaking work in preimplantation genetic testing, having co-developed Karyomapping—a universal diagnostic test used to treat over 50,000 patients worldwide. His research spans human fertility and embryology, comparative genomics, and chromosome evolution, with particular expertise in applying genomic technologies to improve reproductive outcomes and agricultural breeding programs. Professor Griffin brings extensive experience in translating cutting-edge genetic research into clinical applications and commercial solutions, making him an invaluable advisor for genomics companies focused on reproductive health and diagnostics.
Emily Wiseman PHD
Emily Wiseman is a molecular biologist with deep expertise in assay development, single-cell genomics, and method innovation. She has led cross-functional teams in advancing next-generation sequencing technologies, contributed to a pending patent in novel genomics workflows, and delivered validated solutions across ddPCR, qPCR, and RNA single-cell sequencing platforms. Emily earned her Ph.D. in Cell and Molecular Biology from the Florida Institute of Technology, where her research pioneered transcriptomic and proteomic analyses of fertilization processes. At Nova Genomics, she brings a proven track record of scientific excellence, technical leadership, and innovation to accelerate reproductive genetics and clinical applications.
why choose nova genomics?
Founders with Deep IVF Expertise
NOVA Genomics’ founders benefit from over 50 years of combined experience in embryology and reproductive genetics, ensuring a profound understanding of the field.
Specialization in Genetics
As experts in genetics with over 35 years of clinical experience, the NOVA Genomics team offers best in class genetic testing options for patients in need of PGT-M, PGT-SR and PGT-A.
Commitment to Accessibility
Recognizing the importance of equitable healthcare, NOVA Genomics emphasizes expanding access to advanced genetic services, particularly for underserved communities.
Transparent and Ethical Practices
NOVA Genomics prioritizes clarity and integrity in its operations, ensuring that patients and clinics receive straightforward, trustworthy information.
Purpose-Built Laboratory Infrastructure
Unlike many competitors that have evolved from existing frameworks, NOVA Genomics was designed from the ground up to address specific gaps in PGT, focusing on modern technology, quality, and compliance.
Integration of Cutting-Edge Technology
By leveraging the latest advancements in genetic testing, NOVA Genomics ensures high accuracy and reliability in its results, setting a new standard in the industry.
Collaborative Approach with Clinics
Understanding the nuances of IVF treatments, NOVA Genomics works closely with clinics to provide seamless integration of its testing services, enhancing overall patient care.
RESOURCES
Test Request Form (TRF)
DOWNLOAD THE FORM
Biopsy Sample Records
DOWNLOAD THE FORM
handling instructions
DOWNLOAD THE FORM
Connect with our
team of experts
to learn more about PGT and IVF support
Whether you’re a patient exploring fertility options or a provider looking to collaborate, our team is here to help. Submit the contact form to connect with our experts and learn more about our advanced genetic testing services, including PGT-A, PGT-M, and PGT-SR, and discover how NOVA Genomics can support your reproductive journey.
Reimagining the Future of Genetic Testing
Revolutionizing the preimplantation genetic testing laboratory allowing for greater access, accuracy, and clinical impact
CONTACT OUR TEAM TO LEARN MORE
Transforming Genetic Testing with
Experience
and
Innovation
At NOVA Genomics, we are reimagining preimplantation genetic testing (PGT). Founded by industry veterans Dr. Gary Harton and Cynthia Hudson, NOVA brings together cutting-edge technology and a new standard of care to help patients and IVF providers navigate the complexities of genetic testing through informed decision making.
Our team is developing an advanced platform that will serve as the foundation for our contribution to the future of reproductive genetic testing.
UNDERSTANDING PREIMPLANTATION GENETIC TESTING
PGT is a genetic screening test performed on embryos created by in vitro fertilization (IVF). PGT results may be used by physicians in the IVF clinic setting in their clinical decision making.
At NOVA Genomics, we analyze embryos for chromosomal abnormalities, such as extra or missing chromosomes, as well as single-gene disorders and structural chromosomal rearrangements that can lead to inherited genetic conditions.
PGT is offered as three options: PGT-A, PGT-M, and PGT-SR, each designed to address different genetic concerns.
PGT-
A
Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a genetic test to screen embryos for numerical chromosome changes (i.e. Down syndrome). This test identifies embryos predicted to have the expected complement of chromosomes.
PGT-
SR
Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) is a genetic test used during IVF to screen embryos for unbalanced chromosomal structures caused by inherited rearrangements like translocations or inversions.
PGT-
M
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a genetic test performed on embryos to screen for and diagnose inherited variants that cause monogenic (single-gene) disorders (i.e. cystic fibrosis, sickle cell anemia).
nova genomics: A
Modern Approach
to Preimplantation Genetic Testing
NOVA Genomics was founded by two pioneers in the IVF industry. Cynthia Hudson and Dr. Gary Harton, who bring over 50 years of combined experience in Embryology and Preimplantation Genetic Testing (PGT). After decades of work, they recognized critical gaps in the field, including outdated lab technologies, growing concerns about quality and compliance, and ongoing debates over the clinical value of PGT.
Their response was to build a next-level PGT lab from the ground up, focused on expanding access to advanced genetic services for families in need of PGT-SR and PGT-M testing for inherited conditions.
our mission
NOVA Genomics exists to transform preimplantation genetic testing by making high-precision, clinically meaningful insights accessible to every IVF journey. We are driven to close the gaps in technology, quality, and equity by building a new model for genetic testing – one rooted in scientific excellence, patient-centered care, and uncompromising standards.
Driven by this mission, NOVA Genomics is transforming the PGT experience through:
leadership
in education
We are committed to educating our customers and the broader community about the science and benefits of PGT. By promoting awareness and understanding, we support informed decision-making throughout the IVF and genetic screening process.
excellence in
genetic counseling
We've partnered with premier GC services to offer our patients unparalleled support and education throughout their journey. With flexible communication options including live consultations and results discussions with certified genetic counselors, patients and providers are supported both before and after testing.
strategic
partnerships
With an industry-leading management team, we are forging strategic partnerships with leading reagent and software providers to guarantee that our patients and clinical partners have access to the most advanced, reliable, and effective tools in reproductive genetics.
innovation
technology platform
We are developing a new and more effective PGT platform that prioritizes high-quality genetic insights. Our focus is on delivering accurate results that put patient needs and scientific integrity at the forefront of fertility care.
Our partners
PatientFi is designed to take the financial stress out of building your family. Our customized fertility financing solutions make it easier to focus on what really matters—your treatment and your journey—not the cost.
Every plan is tailored to your needs, with flexible terms and simple monthly payments that work within your budget. Whether you’re just starting or continuing treatment, we’ve got you covered.
Expert genetic counseling, seamlessly integrated.
Through our partnership with Tandem Genetics, clinics have access to experienced telehealth counselors for pre- and post-testing sessions. This service streamlines care and ensures individuals pursuing IVF with PGT receive clear guidance on results and next steps.
Learn more about Tandem Genetics’ virtual counseling services.
IVF Store, your Everything IVF partner, is a full-service online marketplace representing the industry’s finest products and solutions, backed by exceptional customer service and support. By adding convenient access to advanced genetic testing alongside their comprehensive offerings, we give clinics a single, reliable partner for both everyday needs and next-generation services.
Meet the
Experts
Behind NOVA Genomics
founders
Gary Harton PhD
Chief Scientific Officer
Gary brings 35 years of experience covering embryology and andrology, molecular and classic cytogenetics, next-generation sequencing, and clinical genetics.
Cynthia Hudson
Chief Executive Officer
Cynthia is a medical technologist with over 25 years of experience as an embryologist, entrepreneur, and product specialist.
clinical team
Harvey Stern MD, PhD (FABMGG)
Medical Director
Dr. Stern is a Board-Certified Clinical & Molecular Geneticist specializing in Reproductive Genetics. He has over 30 years of experience as Medical Director of Preimplantation Genetic Testing and Molecular Genetics laboratories.
Mary Sands, MS, CGC
Director of Clinical Services
Mary is a Certified Genetic Counselor specializing in reproductive genetics with over 20 years of experience managing laboratory and clinical integration in the IVF clinic setting.
laboratory team
Brian Mariani PhD
Director Laboratory Services
Brian has conducted extensive research in cell and molecular biology, exploring aspects of gene organization and how genetic information is expressed and regulated in the context of early developmental biology processes.
Khoa Tran
Lab Team Lead SNV
Khoa has 20 years of research and clinical experience applying molecular diagnostics to the field of reproductive genetics.
Veronica Novik PhD
Lab Team Lead CNV
Veronica is a laboratory professional with over two decades of experience in academic research and clinical laboratory leadership. Recently serving as Assistant Director at the Genetics and IVF Institute, she led cutting-edge initiatives in PGT and molecular diagnostics.
Gabrielle Byers
BS Lab Intern
Gabrielle is a current biotechnology graduate student with a background in Biology and a growing foundation in Computational Genomics and Molecular Science.
Advisors
Darren K Griffin PHD
Professor Darren Griffin is a distinguished geneticist and reproductive medicine expert who serves as Honorary Professor at University College London and the University of Kent, and CEO of GriffinLore Ltd. With over 400 peer-reviewed publications and a citation count exceeding 24,000, he is internationally recognized for his groundbreaking work in preimplantation genetic testing, having co-developed Karyomapping—a universal diagnostic test used to treat over 50,000 patients worldwide. His research spans human fertility and embryology, comparative genomics, and chromosome evolution, with particular expertise in applying genomic technologies to improve reproductive outcomes and agricultural breeding programs. Professor Griffin brings extensive experience in translating cutting-edge genetic research into clinical applications and commercial solutions, making him an invaluable advisor for genomics companies focused on reproductive health and diagnostics.
Emily Wiseman PHD
Emily Wiseman is a molecular biologist with deep expertise in assay development, single-cell genomics, and method innovation. She has led cross-functional teams in advancing next-generation sequencing technologies, contributed to a pending patent in novel genomics workflows, and delivered validated solutions across ddPCR, qPCR, and RNA single-cell sequencing platforms. Emily earned her Ph.D. in Cell and Molecular Biology from the Florida Institute of Technology, where her research pioneered transcriptomic and proteomic analyses of fertilization processes. At Nova Genomics, she brings a proven track record of scientific excellence, technical leadership, and innovation to accelerate reproductive genetics and clinical applications.
why choose nova genomics?
Founders with Deep IVF Expertise
NOVA Genomics’ founders benefit from over 50 years of combined experience in embryology and reproductive genetics, ensuring a profound understanding of the field.
Specialization in Genetics
As experts in genetics with over 35 years of clinical experience, the NOVA Genomics team offers best in class genetic testing options for patients in need of PGT-M, PGT-SR and PGT-A.
Commitment to Accessibility
Recognizing the importance of equitable healthcare, NOVA Genomics emphasizes expanding access to advanced genetic services, particularly for underserved communities.
Transparent and Ethical Practices
NOVA Genomics prioritizes clarity and integrity in its operations, ensuring that patients and clinics receive straightforward, trustworthy information.
Purpose-Built Laboratory Infrastructure
Unlike many competitors that have evolved from existing frameworks, NOVA Genomics was designed from the ground up to address specific gaps in PGT, focusing on modern technology, quality, and compliance.
Integration of Cutting-Edge Technology
By leveraging the latest advancements in genetic testing, NOVA Genomics ensures high accuracy and reliability in its results, setting a new standard in the industry.
Collaborative Approach with Clinics
Understanding the nuances of IVF treatments, NOVA Genomics works closely with clinics to provide seamless integration of its testing services, enhancing overall patient care.
RESOURCES
Test Request Form (TRF)
DOWNLOAD THE FORM
Biopsy Sample Records
DOWNLOAD THE FORM
handling instructions
DOWNLOAD THE FORM
Connect with our
team of experts
to learn more about PGT and IVF support
Whether you’re a patient exploring fertility options or a provider looking to collaborate, our team is here to help. Submit the contact form to connect with our experts and learn more about our advanced genetic testing services, including PGT-A, PGT-M, and PGT-SR, and discover how NOVA Genomics can support your reproductive journey.